ATS 2024 Final Program

Click on the session title to view the speakers

208

MONDAY • MAY 20

3:27 Peepi-induced Inspiratory Threshold Workload Is Reduced Both by High Flow Nasal Cannula Device and Non-invasive Positive Pressure Ventilation in Severe Stable Chronic Obstructive Pulmonary Disease Patients 3:39 Unveiling 2-year Functional Outcomes in COVID-19 Survivors: Breaking Results From a Multi-center Prospective Cohort Study

4:03 Monocyte-derived Interstitial Macrophages Promote Lung Regeneration by Regulating Extracellular Matrix Degradation and Angiogenesis

BEHAVIORAL • CLINICAL MINI SYMPOSIUM

B99 SLEEP APNEA UNPLUGGED:

NAVIGATING A MYRIAD OF HEALTH OUTCOMES

BASIC • TRANSLATIONAL MINI SYMPOSIUM

2:15 p.m. - 4:15 p.m.

San Diego Convention Center Room 32A-B (Upper Level)

B98 HEALING LUNGS: NAVIGATING THE PATHWAYS OF LUNG REPAIR 2:15 p.m. - 4:15 p.m. San Diego Convention Center Room 6D (Upper Level) Featured Speaker Presentation: 2:15 Mitochondrial Integrated Stress Response Controls Lung Epithelial Cell Fate Oral Presentations: 2:27 QKI Is Essential for Maintaining Alveolar Integrity in Mice 2:39 Sustained Activation of Yap/Taz After Injury Leads to Aberrant Alveolar Differentiation and Failure of Alveolar Repair 2:51 Epithelial HIF Activation Impairs Distal Airway Derived Alveolar Repair 3:03 Plasma Biomarkers Reveal Insights into Pathology of Transitional Epithelial States in Pulmonary Fibrosis and Interstitial Lung Abnormalities 3:15 The Mesenchymal Niche in Lung Development and Repair Post-ARDS 3:27 Transcriptional Landscape of Fibroblast Populations During the Resolution of Pulmonary Fibrosis 3:39 A Novel Fibroblast Population Supports Repair of the Alveolar Niche: Insights From a Preclinical Mouse Model of Idiopathic Pulmonary Fibrosis 3:51 Loss of ERG in Capillary Endothelial Cells Is Associated With cGAS-STING Pathway Activation and Aberrant Lung Fibrosis Resolution’

Oral Presentations: 2:15 Hypoxic Burden but Not AHI Predicts Risk of Cardiovascular Events: A Secondary Analysis of the RICCADSA Clinical Trial 2:27 Using Explainable AI to Predict Survival Curves for All-cause Mortality in Obstructive Sleep Apnea 2:39 Mortality and Cardiovascular Changes in a Prolonged Murine Model of OSA 2:51 Association Between Respiratory Event-related Hypoxemia, Autonomic Responses to Respiratory Events and Chronic Kidney Disease in Obstructive Sleep Apnea 3:03 Evaluation of the Framingham Risk Score’s Predictive Performance in Obstructive Sleep Apnea Cohorts: Insights From the SAVE, RICADDSA, and ISAACC Trials 3:15 All-cause Mortality in Obstructive Sleep Apnea: Systematic Literature Review Including Randomised Trials and Confounding Adjusted Non-randomised Controlled Studies and Meta-analysis of Positive Airway Pressure Treatment 3:27 Contribution of Apnea and Non-apnea Related Oxygen Desaturations to the Risk of Cardiovascular Mortality in Sleep Apnea 3:39 Association of Obstructive Sleep Apnea (OSA) Severity With Accelerated Biological (Epigenetic) Aging

ATS 2024 Conference Program • San Diego, CA